Companies: 10,795·Total market cap: $144.5T
Heartflow, Inc. Common Stock

Heartflow, Inc. Common Stock

HTFLNASDAQHealthcare● Active
$28.79
+$0.69(+2.46%)
Market Cap$2.5B
P/E Ratio
52W High$41.223
52W Low$20.13
Overview

Heartflow, Inc. Common Stock (HTFL) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

HTFL · free cash flow · updated Jun 8, 2026

Core FCF metrics

Free cash flow was −$59.0M for FY2025 (fiscal year ending 2025-12-31), up 19.5% year-over-year The FCF margin was -33.5%.

FY2025 Free Cash Flow−$59.0M▲ +19.5% YoY
Trailing 12M (TTM)−$76.8Mtrailing 4 quarters sum
FCF Margin-33.5%−$59.0M ÷ revenue
3-Year CAGRN/AN/A — contains negative FCF
5-Year CAGRN/AN/A — contains negative FCF
FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0
Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

Positive FCFNegative FCF
Free Cash Flow
YoY Growth %
htfl free cash flow history · htfl free cash flow chart · htfl free cash flow growth rate · htfl free cash flow last 10 years

Annual free cash flow data

Fiscal YearFree Cash FlowYoY ChangeFCF Margin
FY2025Latest−$59.0M▲ +19.5%-33.5%
FY2024−$73.4M▲ +11.1%-58.3%
FY2023−$82.5M-94.7%
FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP
htfl free cash flow 2025 · htfl free cash flow 2024 · htfl free cash flow 2023 · htfl operating cash flow

FCF valuation metrics

Heartflow, Inc. Common Stock (HTFL) reported negative free cash flow of −$0.06B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)
N/A
Free Cash Flow ÷ Market Cap
per FMP freeCashFlowYieldTTM definition
FCF per Share (TTM)
N/A
TTM FCF ÷ Shares Outstanding
Price / FCF
N/A
Share Price ÷ FCF per Share
EV / FCF (TTM)
N/A
Enterprise Value basis
!

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31
htfl price to free cash flow · htfl free cash flow yield · htfl free cash flow per share · htfl price to cash flow ratio

Cash flow statement summary

For FY2025, Heartflow, Inc. Common Stock generated −$54.0M in operating cash flow and spent 5M in capital expenditures, yielding −$59.0M in free cash flow.

Operating Activities
−$54.0M
Cash from core business operations
2025-12-31
Investing Activities
−$238.6M
CapEx, acquisitions & investments
2025-12-31
Financing Activities
+$286.0M
Buybacks, dividends & debt
2025-12-31
FCF FormulaOperating CF (−$54.0M) − |CapEx| (5M) = FCF (−$59.0M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement
htfl cash flow statement · htfl cash flow statement 2025 · htfl operating cash flow · htfl cash flow from operations

Free cash flow vs peers (Healthcare)

#CompanyFree Cash FlowYoY
#1
Heartflow, Inc. Common Stock
Heartflow, Inc. Common StockYOU
HTFL
−$59.0M+19.5%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$19.70B-0.7%
#3
AbbVie Inc.
AbbVie Inc.
ABBV
$17.82B-0.1%
#4
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$16.07B-22.4%
#5
Eli Lilly and Company
Eli Lilly and Company
LLY
$8.97B+2065.6%
Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Heartflow, Inc. Common Stock (HTFL) reported free cash flow of −$59.0M for FY2025 (fiscal year ending 2025-12-31), up 19.5% year-over-year. The FCF margin was -33.5%.

Heartflow, Inc. Common Stock has reported negative free cash flow in recent periods, indicating capital expenditures have exceeded operating cash flow. Data available for 3 fiscal years.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Frequently asked questions

HTFL free cash flow · 8 questions

Heartflow, Inc. Common Stock free cash flow was −$59.0M for FY2025, up 19.5% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$76.8M.

HTFL free cash flowHTFL FCFHTFL FCF 2025HTFL free cash flow TTM

Source: FMP /cash-flow-statement · US GAAP · Heartflow, Inc. Common Stock · Heartflow, Inc. Common Stock SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026